|
GMPS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.428000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.108100E-02 |
| Normal-vs-Stage2 |
4.389000E-01 |
| Normal-vs-Stage3 |
7.581400E-01 |
| Normal-vs-Stage4 |
4.786200E-02 |
| Stage1-vs-Stage2 |
9.188200E-01 |
| Stage1-vs-Stage3 |
2.739600E-01 |
| Stage1-vs-Stage4 |
2.377400E-01 |
| Stage2-vs-Stage3 |
5.667800E-01 |
| Stage2-vs-Stage4 |
3.547200E-01 |
| Stage3-vs-Stage4 |
8.950200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.677800E-02 |
| Normal-vs-AfricanAmerican |
1.546630E-01 |
| Normal-vs-Asian |
4.565400E-01 |
| Caucasian-vs-AfricanAmerican |
1.700420E-03 |
| Caucasian-vs-Asian |
9.559000E-01 |
| AfricanAmerican-vs-Asian |
2.357200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.116800E-01 |
| Normal-vs-Female |
2.404200E-02 |
| Male-vs-Female |
2.584000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.383700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.532000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.897200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.959200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.801790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.167000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.183500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.142600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.110400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.728600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.501400E-01 |
| Normal-vs-Grade 2 |
1.112190E-01 |
| Normal-vs-Grade 3 |
6.597000E-01 |
| Normal-vs-Grade 4 |
3.505600E-02 |
| Grade 1-vs-Grade 2 |
9.645800E-01 |
| Grade 1-vs-Grade 3 |
7.075400E-01 |
| Grade 1-vs-Grade 4 |
2.598800E-01 |
| Grade 2-vs-Grade 3 |
2.232200E-01 |
| Grade 2-vs-Grade 4 |
1.510200E-01 |
| Grade 3-vs-Grade 4 |
5.368300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.710200E-01 |
| Normal-vs-ccB subtype |
2.081600E-03 |
| ccA subtype-vs-ccB subtype |
1.528060E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.417800E-02 |
| Normal-vs-N1 |
2.528200E-02 |
| N0-vs-N1 |
7.777500E-02 |
|
|
